Komori
Sysmex (6869) · InitiativeFirst stated

Joint research with Kobe University on a SARS-CoV-2 T-cell immune response testing method

First written in FY2021-Q3. . Latest entry: FY2021-Q3.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Joint research with Kobe University on a SARS-CoV-2 T-cell immune response testing methodA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2021-Q3First statedAnnual report

    「December 2020: Kobe University and the company conducted joint research on an ELISPOT method capable of detecting T-cell immune responses to SARS-CoV-2 as a new blood test method for COVID-19, and announced an overview and the results of its clinical evaluation.」

    Through joint research with Kobe University, the company announced an overview and the results of the clinical evaluation of an ELISPOT method for detecting T-cell immune responses to SARS-CoV-2.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Sysmex yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Joint research with Kobe University on a SARS-CoV-2 T-cell immune response testing method | SYSMEX CORPORATION (6869) | Komori